Some researchers prefer to add more water (3-5 mL) to create a more dilute solution that requires a larger, easier-to-measure draw
The most commonly reported side effects are mild and transient, including injection site reactions (redness, slight swelling, or tenderness), mild headaches during the initial days of use, and occasional dizziness or lightheadedness, particularly when starting the peptide

Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters

Proper medical supervision is essential
Older age History of a previous thrombotic event Smoking Chronic venous disease Atherosclerosis Abnormal lipid levels Hypertension Type 2 diabetes Obesity Sleep apnea Prolonged inactivity Hospitalization or surgery Infection, transplant, and transfusion reactions Pregnancy Cancer Use of high-dose oral estrogens (eg, hormone replacement therapy or a high-dose birth control pill) How are Blood Clots Treated
Their skin feels tender, and they may feel the painful parts are inflamed, but there is no swelling